• USD 11095.31
  • RUB 173.84
  • EUR 10772.44

Elon Musk's brain chip company Neuralink has received regulatory approval to conduct human clinical trials, as shared by the company on Twitter.

“We are pleased to announce that we have received FDA approval to begin human clinical trials. This is an important first step that will one day allow our technology to help many people,” the message says.

Information about the recruitment of participants for clinical trials is said to be announced soon.

Elon Musk created Neuralink in 2017. Two years later, he presented a prototype of the company's main product - a chip implanted in the brain that can be connected to a computer. Elon Musk called the creation of a “brain-computer” interface allowing people to eliminate the consequences of injuries to the brain and spinal cord in the future and, with the help of an implant, replenish lost abilities as the main goal of Neuralink. The company has already successfully implanted such a chip into the brain of a monkey.

Top headlines
President of Uzbekistan Shavkat Mirziyoyev to attend 'European Union - Central Asia' summit in Kyrgyzstan
 CIS Secretary General, Sergei Lebedev urges to unite against “external aggression”
OSCE assists Turkmenistan in border management, environment and women’s empowerment - Helga Schmid